Collegium Pharma (COLL) Earnings
|
Expand Research on COLL
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +7.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +11.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/26  |
Q126 | N/A | $1.82 | N/A | N/A | $194.43M | N/A | N/A | N/A | ||
| 2/26/26 |
Q425 | N/A | $2.14 | N/A | N/A | $207.07M | = | N/A | N/A | ||
| 11/6/25 | Q325 | $2.25 | $1.88 | +$0.37 | $209.36M | $190.12M | = |  | | Details | |
| 8/7/25 | Q225 | $1.68 | $1.66 | +$0.02 | $188M | $182.69M | = | | | Details | |
| 5/8/25 |
Q125 | N/A | $1.50 | N/A | N/A | $174.04M | = | N/A | N/A | ||
| 2/27/25 | Q424 | $1.75 | $1.66 | +$0.09 | $181.9M | $179.48M | = | | | Details | |
| 2/20/25 |
Q424 | N/A | $1.66 | N/A | N/A | $179.48M | = | N/A | N/A | ||
| 11/7/24 | Q324 | $1.61 | $1.57 | +$0.04 | $159.3M | $156.88M | = | | | Details |
